Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesPsyBio Therapeutics Corp

PsyBio Therapeutics Corp

Healthcare Biotechnology
PortfolioPortfolio WatchlistWatchlist
Company price
None CAD 0.00(0%)
Last update at 2024-05-09T10:20:36.478986Z
Market Cap
1.28M

Momentum Score

…

PsyBio Therapeutics Corp., a biotechnology company, engages in the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States. PsyBio Therapeutics Corp. was formerly known as Leo Acquisitions Corp. and changed its name to PsyBio Therapeutics Corp. in January 2021. The company is headquartered in Denver, Colorado.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
0.01
Low
0.09
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
-
Dividend Yield
-
Revenue TTM
0.00M
Revenue Per Share
-
Gross Profit TTM
-1.56M
Debt / Equity
-
ROE
-867.30%
Net Debt
-
ROCE
308.65%
Diluted EPS TTM
-0.03

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31
Income before tax -4.89M -11.02M -
Net income -4.89M -11.02M -
Selling general administrative 3.95M 10.28M -
Gross profit -0.05M -0.06M -
Reconciled depreciation 0.15M - -
Ebit - -9.04M -6.44M
Ebitda -4.71M -10.91M -
Operating income -4.76M -10.91M -
Interest expense 0.02M 0.00M 0.00M
Net interest income -0.02M - -
Total revenue 0.00M 0.00M -
Total operating expenses 4.76M 10.91M -
Cost of revenue 0.05M 0.06M -
Total other income expense net -0.11M -0.11M -
Net income from continuing ops -4.89M -11.02M -
Net income applicable to common shares - -11.02M -6.44M
Breakdown 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31
Total assets 0.39M 4.01M -
Total liab 1.98M 1.29M -
Total stockholder equity -1.59M 2.72M -
Other current liab - 0.60M 0.50M
Common stock - 16.97M 4.93M
Capital stock 16.88M 16.97M -
Retained earnings -21.80M -16.92M -5.90M
Other liab - 0.25M -
Other assets - 0.01M -
Cash 0.00M 0.12M -
Total current liabilities 1.93M 1.04M 1.02M
Other stockholder equity - 2.67M 0.23M
Total current assets 0.25M 4.00M 0.29M
Net tangible assets - 2.72M -0.74M
Short term investments 0.00M 3.68M -
Accounts payable 1.33M 0.39M 0.42M
Non current assets total 0.14M 0.01M -
Capital lease obligations 0.14M - -
Breakdown 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31
Investments 3.52M -3.74M -3.74M
Change to liabilities - 0.49M 0.57M
Total cashflows from investing activities - -3.56M -3.56M
Total cash from financing activities -0.05M 10.37M 1.16M
Change to operating activities - 0.16M 0.53M
Net income -4.89M -11.02M -6.44M
Change in cash 0.03M -0.15M 0.29M
Begin period cash flow 0.12M 0.27M -
End period cash flow 0.16M 0.12M 0.27M
Total cash from operating activities -3.44M -6.95M -0.86M
Issuance of capital stock 0.16M 11.28M -
Depreciation 0.15M - -
Change to account receivables - 0.01M 0.01M
Sale purchase of stock -0.09M - -
Other cashflows from financing activities - -0.91M -0.91M
Change to netincome - 3.40M 4.47M
Capital expenditures 0.00M 0.00M 0.00M
Change in working capital 0.61M 0.67M -
Stock based compensation 0.51M 2.13M -
Other non cash items 0.02M 1.19M -
Free cash flow -3.44M -6.95M -

Peer Comparison*

Sector: Healthcare Industry: Biotechnology

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to EBITDA (x)
SHRX
Sharp Therapeutics Corp.		 -
-%		 1.37 - - - 32.37 -
NRX
NurExone Biologic Inc.		 -0.01
2.00%		 0.49 - 6.90 - 15.26 -7.24
MIR
MedMira Inc		 -
-%		 0.06 - - 223.37 - -80.03
TTI
Thiogenesis Therapeutics Corp.		 -
-%		 0.63 - - - 15.17 -58.16

Profile*

PsyBio Therapeutics Corp

PsyBio Therapeutics Corp., a biotechnology company, engages in the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States. PsyBio Therapeutics Corp. was formerly known as Leo Acquisitions Corp. and changed its name to PsyBio Therapeutics Corp. in January 2021. The company is headquartered in Denver, Colorado.

4400 West Sample Road, Coconut Creek, FL, United States, 33073

513 449 9585

https://www.psybiolife.com

Name Title Year Born
Mr. Evan Mike Levine Co-Founder, CEO & Chairman 1966
Mr. Noah Isidore Davis CFO, Sec. & Director 1983
Dr. Michael Spigarelli M.B.A., M.B.E., M.D., Ph.D. Chief Scientific Officer & Chief Medical Officer 1966
Mr. Ross Carmel Chief Legal Officer & Director 1982
Mr. Andrew Jones Inventor & Chairman of Scientific Advisory Board NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

PRL
CAD 30.50
+15.05%
DSV
CAD 11.02
+14.55%
USA
CAD 4.29
+13.19%
NUAG
CAD 7.70
+12.90%
GMIN
CAD 43.79
+12.86%
DRUG
CAD 26.11
-29.58%
HUT
CAD 68.98
-22.41%
UCU
CAD 2.09
-14.34%
VET
CAD 14.87
-14.29%
PHX
CAD 10.96
-13.56%

Equity Sectors*

  • Basic Materials

    +5.46%

  • Communication Services

    +3.38%

  • Consumer Cyclical

    +3.11%

  • Consumer Defensive

    +1.35%

  • Energy

    -4.79%

  • Financial Services

    +2.66%

  • Healthcare

    -0.72%

  • Industrials

    -0.11%

  • Real Estate

    +1.84%

  • Technology

    +1.05%

  • Utilities

    +0.39%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…